NDC 60687-492 – Buprenorphine
Buprenorphine Hydrochloride 8 mg/1 · Tablet · Sublingual
Product NDC60687-492
Product details
- Brand name
- Buprenorphine
- Generic name
- Buprenorphine
- Labeler
- American Health Packaging
- Dosage form
- Tablet
- Route
- Sublingual
- Marketing category
- ANDA · ANDA207276
- Marketed since
- February 6, 2020
- Listing expires
- December 31, 2026
- Pharmacologic class
- Partial Opioid Agonist
Active ingredients
- Buprenorphine Hydrochloride 8 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 60687-492-21 | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-492-21) / 1 TABLET in 1 BLISTER PACK (60687-492-11) | Feb 6, 2020 |
Recalls mentioning this NDC
- D-0840-2026 Sep 9, 2026 · Class III
Labeling: Label Mix-up
Other Buprenorphine products
- 50090-5805 Buprenorphine Hydrochloride 8 mg/1 · Tablet · A-S Medication Solutions
- 0228-3153 Buprenorphine Hydrochloride 8 mg/1 · Tablet · Actavis Pharma, Inc.
- 0228-3156 Buprenorphine Hydrochloride 2 mg/1 · Tablet · Actavis Pharma, Inc.
- 60687-481 Buprenorphine Hydrochloride 2 mg/1 · Tablet · American Health Packaging
- 69238-1202 Buprenorphine 5 ug/h · Patch, Extended Release · Amneal Pharmaceuticals NY LLC
- 69238-1205 Buprenorphine 20 ug/h · Patch, Extended Release · Amneal Pharmaceuticals NY LLC
- 69238-1505 Buprenorphine 7.5 ug/h · Patch, Extended Release · Amneal Pharmaceuticals NY LLC
- 69238-1204 Buprenorphine 15 ug/h · Patch, Extended Release · Amneal Pharmaceuticals NY LLC
- 69238-1203 Buprenorphine 10 ug/h · Patch, Extended Release · Amneal Pharmaceuticals NY LLC
- 3215-1525 Buprenorphine 20 ug/h · Patch, Extended Release · Aveva Drug Delivery Systems Inc.
- 3215-1521 Buprenorphine 5 ug/h · Patch, Extended Release · Aveva Drug Delivery Systems Inc.
- 3215-1522 Buprenorphine 7.5 ug/h · Patch, Extended Release · Aveva Drug Delivery Systems Inc.